The number of FDA-cleared 3D-printed medical devices has steadily increased since the first approval in 2010, proving that additive manufacturing (AM) is here to stay. The technology’s value is clear, enabling complex geometries, patient-specific implants and porous structures that enhance bone ingrowth for superior fixation. However, cost remains a key challenge, as AM is often seen as requiring significant machine investment, post-processing, and scaling considerations compared to conventional manufacturing. That perception is changing. This presentation reveals how Amnovis is making 3D-printed implants more cost-effective than ever. Through incremental process optimizations and groundbreaking innovations, we have enhanced efficiency and scalability while maintaining quality and regulatory compliance. Join us to discover how to maximize the value of 3D printing for orthopedic implants and turn cost barriers into competitive advantages. Presented by Amnovis, Booth 822
